Catalyst Wire Dossier Catalyst Wire Dossier

Spio lto Respimat

tiotropium/olodaterol · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Spio lto Respimat, covering 2019-09-30 to 2019-09-30. Get the full timeline:

Most recent: Clinical Trial Update: Effectiveness and Handling of Spiolto® Respimat ® in COPD Patients - Italy

See pricing